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Background: Brain ischemia is known to include neuronal cell death and persisting neurological deficits. A lack of
oxygen and glucose are considered to be key mediators of ischemic neurodegeneration while the exact mechanisms
are yet unclear. In former studies the expression of two different two-pore domain potassium (K2P) channels (TASK1,
TREK1) were shown to ameliorate neuronal damage due to cerebral ischemia. In neurons, TASK channels carrying
hyperpolarizing K+ leak currents, and the pacemaker channel HCN2, carrying depolarizing Ih, stabilize the membrane
potential by a mutual functional interaction. It is assumed that this ionic interplay between TASK and HCN2 channels
enhances the resistance of neurons to insults accompanied by extracellular pH shifts.
Methods: In C57Bl/6 (wildtype, WT), hcn2+/+ and hcn2-/- mice we used an in vivo model of cerebral ischemia (transient
middle cerebral artery occlusion (tMCAO)) to depict a functional impact of HCN2 in stroke formation. Subsequent
analyses comprise behavioural tests and hcn2 gene expression assays.
Results: After 60 min of tMCAO induction in WT mice, we collected tissue samples at 6, 12, and 24 h after reperfusion.
In the infarcted neocortex, hcn2 expression analyses revealed a nominal peak of hcn2 expression 6 h after reperfusion
with a tendency towards lower expression levels with longer reperfusion times. Hcn2 gene expression levels in
infarcted basal ganglia did not change after 6 h and 12 h. Only at 24 h after reperfusion, hcn2 expression significantly
decreases by ~55%. However, 30 min of tMCAO in hcn2-/- as well as hcn2+/+ littermates induced similar infarct
volumes. Behavioural tests for global neurological function (Bederson score) and motor function/coordination (grip test)
were performed at day 1 after surgery. Again, we found no differences between the groups.
Conclusions: Here, we hypothesized that the absence of HCN2, an important functional counter player of TASK
channels, affects neuronal survival during stroke-induced tissue damage. However, together with a former study on
TASK3 these results implicate that both TASK3 and HCN2 which were supposed to be neuroprotective due to their
pH-dependency, do not influence ischemic neurodegeneration during stroke in the tMCAO model.Background
Ischemic stroke occurs due to an interruption of blood
supply to corresponding areas of the brain, initiating an
ischemic cascade. The depletion of oxygen or glucose in
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stated.events that result in neurodegeneration. Consequently,
this leads to a high rate of permanent disabilities and
even death [1]. Generally, neurotoxicity can be mediated
by ionic imbalances that contribute to apoptosis (pro-
grammed cell death). Many efforts have been spent so
far on investigating neuronal ion channel function and
regulation after stroke in different animal models [2-5].
Cells that undergo apoptosis have a strongly depolarized
membrane potential prior to cell death [6,7]. In contrast,
a hyperpolarized membrane potential has been reported
to be an important mechanism promoting resistance to
apoptosis [8,9]. Thus, an important indicator for neuronalLtd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited. The Creative Commons Public Domain Dedication
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potential. Among others HCN channels (hyperpolariza-
tion-activated and cyclic nucleotide-gated channels, also
known as pacemaker channels) help to maintain a stable
cell membrane potential at rest and thereby define the ex-
citability of CNS neurons [10-13]. For thalamocortical
relay neurons, it could be demonstrated that two ion
channels, which are predominantly active at rest, strongly
influence the resting membrane potential. The hyperpolar-
izing K+ leak current carried by two-pore domain K+ (K2P)
channels is counterbalanced by a depolarizing Ih carried
by HCN channels resulting in a stable resting membrane
potential in thalamic neurons [14,15].
Interestingly, acidification, one initial pathophysio-
logical event after arterial occlusion, inhibits both TASK
[16-19] as well as HCN channels [20,21]. Thereby, the
acidified milieu after arterial occlusion most probably
influences the activity of acid-sensing ion channels as
well as the cell membrane potential. Thus, a future
therapeutic strategy to further stabilise the resting mem-
brane potential of neurons might promote their survival
in an early phase of stroke development.
The HCN channel family comprises four members
(HCN1-4). Currents through HCN channels (Ih) have
unusual characteristics including activation upon hyper-
polarization, permeability to K+ and Na+, as well as
modulation by cyclic AMP [12]. Originally, they were
identified as pace making channels in the heart that set
cardiac rhythm [22-26]. Besides pacing the heart these
channels are recognized as ubiquitous components of
the nervous system. By setting the membrane potential
and input resistance at rest, HCN channels play an im-
portant role to the integrative function and the sensitiv-
ity to synaptic inputs in neurons [12,24]. Channel
malfunction could be linked to central diseases including
epilepsy [13,27]. Hcn2 transcripts were found at high
levels nearly ubiquitously in brains of adult mice, and
the strongest signals were seen in the olfactory bulb,
hippocampus, thalamus and brainstem [28]. Here, we
test the hypothesis that functional HCN2 channels limit
the infarct volumes and improve neurological and motor
abilities in a mouse model of stroke (tMCAO). Based on
their inhibition by acidification which occurs during ar-
terial occlusion one might predict that less active HCN2
channels favour a more hyperpolarized membrane po-
tential and a reduced susceptibility to brain damage.
Methods
Real-time PCR
For hcn2 gene expression ipsilesional neocortices and
basal ganglia of C57Bl6 WT mice (Charles River, Sulzfeld,
Germany) were analysed 6, 12 and 24 h after reperfusion
together with corresponding tissue samples from sham-
operated mice. Tissue homogenization, RNA isolation andreal-time RT-PCR were performed as described [29]. Total
RNA was prepared with a Miccra D-8 power homogenizer
(ART) using the TRIzol reagent® (Invitrogen) and was
quantified spectrophotometrically. Then, 1 μg of total
RNA were reversely transcribed with the TaqMan® Reverse
Transcription Reagents (Applied Biosystems) according to
the manufacturer’s protocol using random hexamers.
Relative gene expression levels of hcn2 (assay ID:
Mn00468538_m1, Applied Biosystems) was quantified
with the fluorescent TaqMan® technology. GAPDH (Taq-
Man® Predeveloped Assay Reagents for gene expression,
part number: 4352339E, Applied Biosystems) was used as
an endogenous control to normalize the amount of sample
RNA. The PCR was performed with equal amounts of
cDNA in the StepOnePlusTM Real-Time PCR System
(Applied Biosystems) using the TaqMan® Universal 2x
PCR Master Mix (Applied Biosystems). Reactions (total
volume 12.5 μl) were incubated at 50°C for 2 min, at 95°C
for 10 min followed by 40 cycles of 15 sec at 95°C and
1 min at 60°C. Water controls were included to ensure spe-
cificity. Each sample was measured in triplicate and data
points were examined for integrity by analysis of the ampli-
fication plot. The comparative Ct method was used for
relative quantification of gene expression as described [30].
Induction of cerebral ischemia
Animal experiments were approved by governmental agen-
cies (Regierung von Unterfranken, Würzburg, Germany,
approval number 54/09) for animal research and con-
ducted according to the recommendations for research
in mechanism-driven basic stroke studies [31], current
ARRIVE guidelines (http://www.nc3rs.org/ARRIVE). Focal
cerebral ischemia was induced in 8-20 weeks old hcn2+/+
and hcn2-/- [13] littermates of either sex weighing 15-30 g
(hcn2+/+: 20-30 g; hcn2-/-: 15-25 g) by transient middle
cerebral artery occlusion (tMCAO) as described previously
[32,33]. Briefly, mice were anesthetized with 2.5% enflurane
(Abbott, Wiesbaden, Germany) in a 70% N2O/30% O2
mixture. Core body temperature was maintained at 37°C
throughout surgery using a feedback-controlled heating de-
vice. Following a midline skin incision in the neck, the
proximal common carotid artery and the external carotid
artery were ligated and a standardized silicon rubber-
coated 6.0 nylon monofilament (6021; Doccol Corp., CA,
USA) was inserted and advanced via the right internal
carotid artery to occlude the origin of the right MCA. The
intraluminal suture was left in situ for 0.5 or 1 hour,
respectively. Then animals were re-anesthetized and the
occluding monofilament was withdrawn to allow reperfu-
sion. After 24 hours neurological deficits were scored by
two blinded investigators and quantified according to
Bederson [34]: 0, no deficit; 1, forelimb flexion; 2, as for 1,
plus decreased resistance to lateral push; 3, unidirectional
circling; 4, longitudinal spinning; 5, no movement. For the
Ehling et al. Experimental & Translational Stroke Medicine 2013, 5:16 Page 3 of 8
http://www.etsmjournal.com/content/5/1/16gript test, the mouse was placed midway on a string be-
tween two supports and rated as follows [35]: 0, falls off; 1,
hangs onto string by one or both forepaws; 2, as for 1, and
attempts to climb onto string; 3, hangs onto string by one
or both forepaws plus one or both hind paws; 4, hangs
onto string by fore- and hind paws plus tail wrapped
around string; 5, escape (to the supports).
Laser-Doppler flowmetry
Laser-Doppler flowmetry (Moor Instruments, Axminster,
United Kingdom) was used to monitor cerebral blood flow
in the right MCA territory (6 mm lateral and 2 mm pos-
terior from bregma) [36] in hcn2+/+ and hcn2-/- (n = 4/
group) before surgery (baseline), immediately after MCA
occlusion (ischemia), and 5 minutes after removal of the
occluding monofilament (reperfusion).
Determination of infarct size
Mice were sacrificed 24 hours after tMCAO. Brains were
quickly removed and cut in 2 mm thick coronal sections
using a mouse brain slice matrix. The slices were stained
with 2% 2,3,5-triphenyltetrazolium chloride (TTC; Sigma-
Aldrich, St. Louis, MO) in PBS to visualize the infarctions
[34]. Planimetric measurements (ImageJ software, National
Institutes of Health, Bethesda, MD) blinded to the treat-
ment groups were used to calculate lesion volumes, which
were corrected for brain edema according to the following
equation: Vindirect (mm
3) = Vinfarct* (1 − (Vih − Vch) / Vch.
The term (Vih − Vch) represents the volume difference be-
tween the ischemic hemisphere and the control hemi-
sphere and (Vih − Vch) / Vch expresses the difference as a
percentage of the control hemisphere [37,38].
Histology
For analysis of the overall brain architecture formalin-
fixed brains from naïve hcn2-/- and hcn2+/+ littermates
were embedded in paraffin-wax, cut into 5 μm thick sec-
tions and stained for cresyl violet. For hematoxylin and




















Figure 1 Time course of hcn2 gene expression in infarcted neocortex
assessed by means of semi-quantitative real-time PCR in infarcted neocorti
at three different time points after reperfusion (6 h, 12 h, 24 h). *p < 0.05, 130 min tMCAO were deeply anesthetized and transcar-
dially perfused with 4% paraformaldehyde (PFA) 24
hours after reperfusion. Thereafter brains were embed-
ded in paraffin-wax and cut into 5 μm thick sections
0.5 mm anterior from bregma (representing the ischemic
territory of the MCA).
Statistical analysis
Data are expressed as mean ± standard deviation (SD)
except for the ordinal Bederson score and the grip test
score that are depicted as scatter plots including median
with the 25% percentile and the 75% percentile given in
brackets in the text. Data were tested for Gaussian distri-
bution with the D’Agostino and Pearson omnibus nor-
mality test and then analyzed by unpaired, 2-tailed
Student’s t-test (infarct volumes) or the nonparametric
Mann–Whitney test (Bederson score and the grip test).
Real-time PCR and Laser-Doppler flowmetry data were an-
alyzed by 1-way ANOVA in case of analyzing the interac-
tions of two independent variables or 2-way ANOVA with
post hoc Bonferroni adjustment for P values in case of
multiple comparisons. p < 0.05 was considered statistically
significant.
Results
Hcn2 gene expression decreases in basal ganglia 24 h
after arterial occlusion
It has been previously shown that mRNA expression of
different cation channels is increased after MCAO in
rats. This overexpression of ion channel genes can be
prevented through the application of the neuroprotective
substance ginsenoside-Rd [39]. Here, we tested whether
transient cerebral ischemia influenced hcn2 expression
levels. Relative hcn2 gene expression values of sham-
treated WT mice in infarcted cortex (1.0 ± 0.1; Figure 1A)
and basal ganglia (1.0 ± 0.1; Figure 1B) were compared
with three different time points (6, 12, 24 h; n = 4-5 per
group) after 60 min of tMCAO. In infarcted cortical tissue





















and basal ganglia after tMCAO. Relative hcn2 gene expression was
cal areas (A) and basal ganglia (B) of sham-treated WT mice as well as
-way ANOVA followed by Bonferroni multiple comparison test.
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points (12 h: 1.03 ± 0.2; 24 h: 0.62 ± 0.3). However, no sig-
nificant differences were detected. Also in infarcted basal
ganglia hcn2 gene expression levels remained unaltered
early after the insult (6 h: 0.87 ± 0.3; 12 h: 1.20 ± 0.4).
However, at 24 h (0.45 ± 0.1) after tMCAO we detected a
significant ~55% reduction of expression levels compared
to sham-treated mice.
Genetic ablation of HCN2 channels has no major impact
on the outcome after tMCAO
Based on the observation that transient arterial occlusion
alters hcn2 gene expression in infarcted basal ganglia 24 h
after surgery, we next investigated the functional role of
HCN2 channels in vivo during experimental cerebral ische-



















Figure 2 Infarct volumes 24 h after 30 min MCA occlusion in hcn2+/+
(TTC) stained images of three corresponding coronal sections (upper panel
white and regularly and include the neocortex and basal ganglia as confirm
(B) Mean brain infarct volumes on day1 after 30 min tMCAO in the two anim
(ns), unpaired, 2-tailed Student’s t-test.hcn2-/- and hcn2+/+ mice to be normal as revealed by cresyl
violet staining of naïve brain sections (Additional file 1:
Figure S1). Since all and 33% of HCN2-deficient and
hcn2+/+ mice died after 60 min of perfusion, we induced
mild ischemia by 30 min of tMCAO which resulted in
a mortality of 31% in hcn2+/+ and hcn2-/- littermates
(5 mice from 16 died in each group, data not shown). 24
hours after reperfusion stroke-induced tissue damage in
both groups was restricted to neocortical areas and
basal ganglia as revealed by TTC-staining of 2 mm-
thick coronal sections (Figure 2A). Hcn2+/+ animals
showed stroke volumes of 36.2 ± 19.3 mm3 while hcn2-/-
mice displayed infarct areas of 40.5 ± 25.2 mm3 (n = 11 per
group; p = 0.66; Figure 2B). As expected from comparable
infarct sizes, no functionally relevant differences could be
found for the Bederson score (median, 2.0 [1.0, 3.0] forHCN2-/-
ns
and hcn2-/- mice. (A) Representative 3,5-Triphenyltetrazoliumchloride
) of control (hcn2+/+) and hcn2-/- mice. Ischemic infarctions appear
ed by haematoxylin and eosin staining (lower panel) (bar: 1 mm).
































Figure 3 HCN2 ablation does not affect neurological and motor functions after 30 min MCA occlusion. Neurological Bederson score (A)
and grip test (B) from the hcn2+/+ and hcn2-/- animals shown in Figure 2 on day1 after 30 min tMCAO. Non-significant differences (ns),
Mann-Whitney test.
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the grip test (median, 3.0 [3.0, 4.0] for hcn2+/+ vs. 3.0 [3.0,
4.0] for hcn2-/-; p = 0.86; Figure 3B). As measured by laser
Doppler flowmetry, no differences in cerebral perfusion
between the groups at any time point could be observed
(Figure 4A). Assessment of the cerebral vasculature by
ink-perfusion revealed identical constitutions in hcn2+/+
and hcn2-/- mice as a complete circle of Willis could be
identified in all animals and the anatomy of the MCA trunk
and branch did not differ between genotypes (Figure 4B).
Discussion
Brain injury following transient or permanent focal cere-
bral ischemia develops from a complex series of patho-
physiological events. Very early after the onset of a
perfusion deficit membrane depolarisation in the core re-
gion of the affected brain tissue and glutamate excitotoxi-














Figure 4 Assessment of the cerebral vasculature in hcn2-/- vs. hcn2+/+
using the Laser-Doppler flowmetry prior (baseline), during (ischemia) and s
deficits were similar in hcn2-/- (grey) and hcn2+/+ mice (black; n = 3 per gro
time point, ns: not significant 2-way ANOVA, Bonferroni‘s post hoc test. (B)
littermates by perfusion with black ink. A complete Circle of Willis was foun
branch was identical in hcn2+/+ and hcn2-/- mice.response as well as apoptosis in later stages of stroke de-
velopment [7]. This study focuses on the impact of HCN2
channels on the early pathophysiological events after ar-
terial occlusion. The findings of the presented study show:
(1) during the course of stroke development hcn2 gene
expression remains stable in infarcted cortical areas and
reveals a significant decrease in affected basal ganglia 24 h
after reperfusion compared to sham-treated animals; (2)
the presence of HCN2 channels does not affect stroke de-
velopment regarding infarct sizes and neurological as well
as motor functions assessed from tMCAO-treated mice.
Although hcn2 gene expression was found to be reduced
in infarcted basal ganglia 24 h after occlusion, it is con-
cluded that with the techniques applied in this study an
impact of HCN2 channels on stroke development in mice
could not be determined.
Since drugs that reduced infarct-induced depolarizations





littermates. (A) Regional cerebral blood flow (rCBF) was monitored
hortly after (reperfusion) 60 min of tMCAO to make sure that perfusion
up). No differences in rCBF were observed between the groups at any
Assessment of the cerebral vasculature in hcn2-/- and control (hcn2+/+)
d in both animal groups and the anatomy of the MCA trunk and
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regarded as one putative therapeutic strategy that inter-
venes stroke development in an early stage. Accordingly,
ion channel function and dysfunction has been investi-
gated intensively. In this study the time course of hcn2
gene expression appeared inconspicuous, except a signi-
ficant down regulation of about 55% in infarcted basal
ganglia 24 h after reperfusion (see Figure 1). In previous
studies altered gene expression levels of functionally
distinct ion channels have already been observed. Overex-
pression of genes encoding a non-selective cation channel
(TRPM7) and two sodium channels (ASIC1a, ASIC2a)
was found in rat brains after 120 min of tMCAO. In that
study pre-treatment with Ginsenoside-Rd, a neuroprotec-
tive substance of the Chinese herb panax ginseng, had no
significant effects on the expression of TRPM1-6 and
glutamate receptors but down regulated MCAO-induced
expression of TRPM7, ASIC1a and ASIC2a [39]. A K+ leak
channel of the K2P family (TREK1) had a beneficial impact
on primary cultured astrocytes during hypoxia. TREK1
protein expression was temporally increased in these cells
at 6 h after hypoxia. However, blockade of TREK1 chan-
nels raised the number of hypoxia-induced neuronal
apoptosis in a neuron-astrocyte co-culture indicating a
neuroprotective role of TREK1 channels after hypoxia
[41]. In line with that, former studies on K2P channels in
stroke also revealed that TASK1 and TREK1 are involved
in neuroprotection after stroke in mice while a closely re-
lated channel (TASK3) had no influence. TREK1-deficient
mice showed an increased vulnerability to ischemia be-
cause neuroprotection through polyunsaturated fatty acids
(TREK1 agonists) which was impressive in wildtype ani-
mals disappeared in TREK1-/- mice [4]. Similarly, the pres-
ence of functional TASK1 channels was beneficial during
stroke in mice since TASK1-/- mice developed significantly
larger infarct volumes accompanied by worse outcome in
functional neurological tests compared to wildtype mice
[3]. Interestingly, TASK3 channels which are functionally
closely related to TASK1 did not affect the outcome after
cerebral ischemia [2].
The membrane potential is shaped by the interplay of
HCN channels with inwardly rectifying K+ channels and
K+ leak channels in mouse cortical [42] and by HCN2/
TASK3 interactions in rat thalamocortical neurons [14].
Thus, we here tested whether HCN2 ablation would inter-
fere with the stability of the membrane potential and
thereby influence stroke pathophysiology. The present find-
ings indicate that HCN2 channels affect neither infarct sizes
(see Figure 2) nor neurological and motor functions (see
Figure 3). HCN channel activation upon hyperpolarization
is an unique characteristic of all HCN channels [22-24]
thereby outbalancing a hyperpolarized membrane potential
(<-80 mV) towards resting values (-60 to -70 mV). More-
over, these channels are sensitive to acidification [20,21] astaking place in ischemic tissue [43]. However, especially the
response of Ih upon hypoxia is well investigated in neurons
of the thalamus [44,45]. During acute thalamic hypoxia an
increased release of noradrenaline, serotonin, histamine
and nitric oxide is responsible for transforming Ih into an
instantaneously activating current. These studies demon-
strate that it is rather the massive release of monoaminergic
transmitters than tissue acidification that influences Ih. This
Ih activation promotes membrane depolarization and finally
neuronal damage. Since ischemia also induces release of
monoamines in the basal ganglia [46], it can be assumed
that HCN channels are also activated by the respective
signaling pathways in these brain regions. However, HCN2
ablation in this study does not affect the extent of neuronal
damage compared to control. Besides HCN2 channels
HCN4 channels are highly while HCN1 and HCN3 are less
sensitive to changes in intracellular cAMP [47,48]. Thus, it
could be worth investigating the role of other HCN family
members, presumably HCN4, in the context of ischemia in
future studies.
Additional file
Additional file 1: Figure S1. Overall brain architecture of hcn2+/+ vs. hcn2-/-
littermates. Independent of HCN2 ablation brain architecture of both groups is
found to be normal as assessed by cresyl violet staining of 5 μm thick coronal
brain sections of naïve hcn2+/+ and hcn2-/- littermates (bar: 1 mm).
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